Prostate cancer is a long-standing Agent Orange presumptive under 38 CFR § 3.309(e). Active treatment or surgery yields a 100% rating under § 4.115b Code 7528; residuals (voiding dysfunction, erectile dysfunction) become the rating after a mandatory re-evaluation 6 months post-treatment.
Top 5 recent grants
Ranked by decision date. Each card shows verbatim Findings of Fact and Reasons & Bases pulled directly from the Board's published decision — no summarization, no AI rewording.
Findings of Fact (verbatim from decision)
A medical nexus between an in-service incurrence and a current diagnosis has been established.
Findings of Fact (verbatim from decision)
The persuasive evidence of record is at least in approximate balance that the Veteran was exposed to herbicides, and his prostate cancer and leukemia are directly related to his active-duty service.
Findings of Fact (verbatim from decision)
1. Resolving reasonable doubt in the Veteran's favor from November 25, 2015 the Veteran was precluded from securing or following a substantially gainful occupation as a result of his service-connected prostate cancer disability. 2. The Veteran's remaining service-connected disabilities did not preclude the Veteran from securing or following a substantially gainful occupation. 3. The Veteran had a permanent and total disability from November 25, 2015 for Dependents' Educational Assistance, in which he was entitled to a TDIU.
Reasons & Bases (verbatim excerpts from decision)
Thus, the applicable appeal period is from November 25, 2015, the effective date of service connection for that disability, through the present. See 38 C.F.R. § 3.400. As of November 25, 2015, the Veteran was service connected for prostate cancer at a 60 percent disability rating; hypothyroidism at a 10 percent disability rating; non-occlusive coronary artery disease rated at 10 percent; symptom complex consistent with pyloroduodenal irritability at 0 percent; erectile dysfunction at 0 percent; residual scars at 0 percent; and hypertension at 0 percent. […] Resolving reasonable doubt in the Veteran's favor, the Board finds that the Veteran's prostate cancer precluded the Veteran from securing or following a substantially gainful occupation throughout the appeal period (November 25, 2015). While the Board acknowledges that the Veteran would possibly be able to do clerical work, with his reports of frequent urination, the Board resolves reasonable doubt in the Veteran's favor that this could possibly preclude him from working. […] However, the Board finds that resolving reasonable doubt in the Veteran's favor, his prostate cancer residuals precluded the Veteran from securing or following a substantially gainful occupation. Thus, an earlier effective date of November 25, 2015 (the entire appeal period), for a TDIU is warranted.
Findings of Fact (verbatim from decision)
Resolving reasonable doubt in the Veteran's favor, the Veteran's prostate cancer cannot be satisfactorily disassociated from his period of service.
Findings of Fact (verbatim from decision)
Resolving all reasonable doubt in favor of the Veteran, he was exposed to herbicide agents while serving in Guam, and his currently diagnosed prostate cancer is due to the herbicide agent exposure.
Get a filed-ready brief on your specific facts — free
The decisions above are the most recent grants — they may not match your specific nexus theory or fact pattern. The NexusVetClaims Precedent Brief runs a semantic search on your exact situation and returns 10 decisions (8 closest analogous matches + 2 instructive contrasts) as a filed-ready PDF with suggested citations and placement guidance for every VA form.
Build my Precedent Brief →One-time payment. Delivered by email within 60 seconds. Powered by real Board of Veterans' Appeals decisions.
How to use these decisions in your claim
- ›Confirm qualifying Agent Orange exposure — Vietnam, Thailand air bases, Korean DMZ during the applicable window.
- ›Active treatment = 100% rating. Don't let the VA reduce prematurely — the regulation requires evaluation 6 months post-treatment.
- ›Post-treatment residuals (voiding dysfunction, ED) deserve their own ratings under SMC-K and the GU rating criteria.
- ›BVA decisions are non-precedential under 38 CFR § 20.1303 but the Board and rating officials regularly find recent analogous decisions persuasive — especially when your facts materially match.
- ›Paste the suggested-citation line into VA Form 21-4138 (Statement in Support of Claim), then attach the full decision PDF as an exhibit.
More BVA grant guides
BVA decisions are public-record Department of Veterans Affairs rulings. Under 38 CFR § 20.1303 they are non-precedential but may be cited as persuasive evidence of how the Board has treated similar facts. NexusVetClaims provides software, not legal representation. This page shows retrieval output from the nexusvetclaims.com BVA corpus and is updated as new decisions are indexed.